Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease

Journal of Neuroscience

Volumn 19, Issue 4, 1999, Pages 1189-1202

  Fusco, Francesca R ^a,e   Chen, Quan ^a   Lamoreaux, William J ^b   Figueredo Cardenas, Griselle ^a   Jiao, Yun ^a   Coffman, Jonathan A ^a   Surmeier, D James ^c   Honig, Marcia G ^a   Carlock, Leon R ^d   Reiner, Anton ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cholinergic interneurons; Corticostriatal neurons; Huntingtin; Huntington's disease; Striatal projection neurons; Striatum

Indexed keywords

CALBINDIN; HUNTINGTIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CHOLINERGIC SYSTEM; CORPUS STRIATUM; GENE MUTATION; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MOTOR CORTEX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRIATE CORTEX; TISSUE DISTRIBUTION;

EID: 0033557661     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-04-01189.1999     Document Type: Article

References (101)

1. Adams J (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457-1463.
2. Albin RL, Tagte DA (1995) Genetics and molecular biology of Huntington's disease. Trends Neurosci 18:11-14.
3. Albin RL, Reiner A, Anderson KD, Penney JB, Young AB (1990a) Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol 27:357-365.
4. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD, Markel DS, Tourtellotte WW, Reiner A (1990b) Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 332:1923-1298.
5. Albin RL, Reiner A, Anderson KD, Dure LS IV, Handelin B, Balfour R, Whetsell Jr WO, Penney JB, Young AB (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol 31:425-430.
6. Anderson KD, Reiner A (1990) The extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. J Comp Neurol 295:339-369.
7. Anderson KD, Reiner A (1991) Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of Dl dopamine receptors on different types of striatal neurons. Brain Res 568:235-243.
8. Aronin N, Chase K, Christine Y, Sapp E, Schwartz C, Matta N, Konreich R, Landwehrmeyer B, Bird E, Beal MF, Vonsattel JP, Smith T, Carraway R, Boyce FM, Young AB, Penney JB, DiFiglia M (1995) CAG Expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. Neuron 15:1193-1201.
9. Arzherger T, Krampfl K, Leimgruber S, Weindl A (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: an in situ hybridization study. J Neuropathol Exp Neurol 56:440-454.
10. Bazzett TJ, Becker JB, Katz KW, Albin RL (1993) Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Exp Neurol 120:177-185.
11. Bazzett TJ, Becker JB, Falik RC, Albin RL (1994) Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity. Neuroscience 60:837-841.
12. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119-130.
13. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171.
14. Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB (1988) Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8:3901-3908.
15. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11:1649-1659.
16. Beal MF, Bradley TH, Koroshetz W (1993a) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125-131.
17. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993b) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitroproprionic acid. J Neurosci 13:4181-4192.
18. Berghorn KA, Bonnett JH, Hoffman GE (1994) cFos immunoreactivity is enhanced with biotin amplification. J Histochem Cytochem 42:1635-1642.
19. Bernard V, Somogyi P, Bolam JP (1997) Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci 17:819-833.
20. Bernier PJ, Parent A (1998) The anti-apoptosis bcl-2 proto-oncogene is preferentially expressed in limbic structures of the primate brain. Neuroscience 82:635-640.
21. Bessert DA, Gutridge KL, Dunbar JC, Carlock LR (1995) The identification of a functional nuclear localization signal in the Huntington's disease protein. Mol Brain Res 33:165-173.
22. Bhide PG, Day M, Sapp E, Schwartz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N, DiFiglia M (1996) Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523-5535.
23. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ (1989) Catalyzed reported deposition, a novel method of signal amplification, application to immunoassays. J Immunol Methods 125:279-285.
24. Bobrow MN, Shaughnessy KJ, Litt GJ (1991) Catalyzed reported deposition, a novel method of signal amplification. II. Application to membrane assays. J Immunol Methods 137:103-112.
25. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muquit MMK, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646-653.
26. Bruyn GW, Went LN (1986) Huntington's chorea. In: Handbook of clinical neurology (Vinken PJ, Bruyn GW, Klawans HL, eds), pp 267-313. Amsterdam: Elsevier.
27. Burke JR, Enghild JJ, Martin ME, You YS, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2:347-350.
28. Byers RK, Gilles FH, Fung C (1983) Huntington's disease in children. Neuropathological study of four cases. Neurology 23:561-569.
29. Cha JHJ, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, Penney JB, Bates GP, Young AB (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci USA 95:6480-6485.
30. Chen Q, Reiner A (1996) Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum. Brain Res 743:346-352.
31. Chen Q, Veenman CL, Reiner A (1996) Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73:715-731.
32. Chen Q, Veenman CL, Knopp K, Yan Z, Medina L, Song WJ, Surmeier DJ, Reiner A (1997) Evidence for the preferential localization of GluR1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience 83:749-761.
33. Chesselet MF, Lin CS, Polsky K, Jin BK (1990) Ischemic damage in the striatum of adults gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Exp Neurol 110:209-218.
34. Cimino GD, Metchette K, Isaacs ST, Zhu YS (1990) More false positive problems (letter/comment). Nature 345:773-774.
35. Cowan RL, CJ Wilson (1994) Spontaneous firing patterns and axonal projections of single corticostriatal neurons in the rat medial agranular cortex. J Neurophysiol 71:17-32.
36. Cowan RL, Wilson CJ, Emson PC, Heizmann CW (1990) Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J Comp Neurol 302:197-205.
37. Cudkowicz M, Kowall NS (1990) Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 27:200-204.
38. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548.
39. De La Monte SM, Vonsattel JP, Richardson Jr EP (1988) Morphometric demonstrations of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 44:516-525.
40. DiFiglia M, Sapp E, Chase K, Schwarts C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmatic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075-1081.
41. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin JP (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neuntes in brain. Science 277:1990-1993.
42. Evers P, Eylings HBM (1994) Microwave-stimulated antigen retrieval is pH and temperature dependent. J Histochem Cytochem 42:1555-1563.
43. Ferrante RJ, Kowall NW, Beal MF, Richardson Jr EP, Bird ED, Martin JB (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-563.
44. Ferrante RJ, Kowall NW, Richardson EP, Bird ED, Martin JB (1986) Topography of enkephalin, substance P, and acetylcholinesterase in Huntington's disease striatum. Neurosci Lett 71:283-288.
45. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson Jr EP (1987a) Morphological and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46:12-27.
46. Ferrante RJ, Beal MF, Kowall NW, Richardson Jr EP, Martin JB (1987b) Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res 411:162-166.
47. Ferrante RJ, Gutenkust CA, Persichetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM (1997) Heterogeneous topographic and cellular distribution of Huntingtin expression in the normal human neostriatum. J Neurosci 17:3052-3063.
48. Ferrer I, Kulisevsky J, Gonzalez G, Escartin A, Chivite A, Casas R (1994) Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in Huntington's disease. Neurodegeneration 3:169-173.
49. Figueredo-Cardenas G, Anderson KD, Chen Q, Veeman CL, Reiner A (1994) Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Exp Neurol 129:37-56.
50. Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A (1996) Colocalization of somatostatin, neuropeptide Y, NADPH-diaphorase and neuronal nitric oxide synthase in striatal interneurons in rats. Brain Res 735:317-324.
51. Figueredo-Cardenas G, Chen Q, Reiner A (1997) Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp Neurol 146:444-457.
52. Figueredo-Cardenas G, Harris C, Anderson KD, Reiner A (1998) Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp Neurol 149:356-372.
53. Goldman-Rakic P, Selemon LD (1986) Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In: Cerebral cortex, Vol 5 (Jones EG, Peters A, eds), pp 447-466. New York: Plenum.
54. Gourfinkel-An I, Cancel G, Trottier Y, Devys D, Tora L, Lutz Y, Imbert G, Saudou F, Stevanin G, Agid Y, Brice A, Mandel JL, Hirsch EC (1997) Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol 42:712-719.
55. Gutekunst CA, Levey AI, Heilman CJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersh SM (1995) Identification and localization on huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci USA 92:8710-8714.
56. Harrington KM, Kowall NM (1991) Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J Neuropathol Expl Neurol 50:309.
57. Hedreen JC, Folstein SE (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54:105-120.
58. Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-261.
59. Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED, Vonsattel JP, DiFiglia M (1995) Quinolinic acid induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Neuroscience 65:397-407.
60. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on HD chromosome. Cell 72:971-983.
61. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996) Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugated enzyme. J Biol Chem 27:19385-19394.
62. Kalchman MA, Hoide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kaemi-Esfarjani P, Lynn FC. Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HIP1, a human homologue of S. cerevisiae Sla2p: interacts with membrane-associated huntingtin in the brain. Nat Genet 16:44-53.
63. Kawaguchi Y, Wilson CJ, Emson PC (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 10:3421-3438.
64. Kincaid AE, Wilson CJ (1996) Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol 374:578-592.
65. Kita H, Kosaka T, Heizmann CW (1990) Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res 536:1-15.
66. Kitai ST, Kita H (1987) Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In: The basal ganglia II. Structure and function: current concepts (Carpenter MB, Jaraman A, eds), pp 357-373. New York: Plenum.
67. Kiyama H, Seto-Ohshima A, Emson PC (1990) Calbindin D28k as a marker for the degeneration of striatonigral pathway in Huntington's disease. Brain Res 525:209-214.
68. Kosinski CM, Cha JH, Young AB, Persichetti F, MacDonald M, Gusella JF, Penney Jr JB, Standaert DG (1997) Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp Neurol 144:239-247.
69. Kowall NW, Ferrante RJ, Martin JB (1987) Pattern of cell loss in Huntington's disease. Trends Neurosci 10:24-29.
70. Landwehrmeyer GB, McNeil SM, Dure IV LS, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E, deYoung M, Avila-Gonzales AJ, Wexler NS, DiFiglia M, Gusella JF, MacDonald ME, Penney JB, Young AB. Vonsattel JP (1995) Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218-230.
71. Lapper SR, Bolam JP (1992) Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience 51:533-545.
72. Li SH, Schilling G, Young III WS, Li XJ, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG, Folstein SE, Hedreen JC, Ross CA (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985-993.
73. Li XJ, Li SH, Sharp AH, Nucifora FC, Schilling Jr G, Lanahan A, Worley P, Snyder SH, Ross CA (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398-402.
74. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrbach H, Davies SW, Bates G (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
75. Martin LJ, Blackstone CD, Levey AI, Huganir RL Price DL (1993) AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53:327-358.
76. Medina L, Figueredo-Cardenas G, Reiner A (1996) Differential abundance of superoxide dismutase in interneurons versus projection neurons in patch versus matrix neurons in monkey striatum. Brain Res 708:59-70.
77. Petralia RS, Wenthold RJ (1992) Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J Comp Neurol 318:329-354.
78. Reiner A, Anderson KD (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res Rev 15:251-265.
79. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 85:5733-5737.
80. Richfield EK, Herkenham M (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol 36:577-584.
81. Richfield EK, Maguire-Zeiss KA, Cox C, Gilmore J, Voorn P (1995) Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann Neurol 37:335-343.
82. Rubinsztein DC, Leggo J, Chiano M, Dodge A, Norbury G, Rosser E, Craufurd D (1997) Genotypes at the GIR6 kainate receptor locus are associated with variation in the age of onset of Huntington's disease. Proc Natl Acad Sci USA 94:3872-3876.
83. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntinglin localization in brains of normal and Huntington's disease patients. Ann Neurol 42:604-612.
84. Sato K, Kiyama H, Tohyama M (1993) The differential expression patterns of messenger RNAs encoding non-NMDA glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52:515-539.
85. Schilling G, Sharp AH, Loev SJ, Wagster M V, Li SH, Stine OC, Ross CA (1995) Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet 4:1365-1371.
86. Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium binding protein containing neurons in Huntington's disease. Lancet 1:1252-1255.
87. Sharp AH. Ross CA (1996) Neurobiology of Huntington's disease. Neurobiol Dis 3:3-15.
88. Sharp AH, Loev SJ, Schiling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DDK, Ross CA (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065-1074.
89. Storey E, Kowall NW, Finn SF, Mazurek MF, Beal MF (1992) The cortical lesion of Huntington's disease: further neurochemical characterization and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate. Ann Neurol 32:526-534.
90. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A, Kitai ST (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 89:10178-10182.
91. Surmeier DJ, Song WJ, Yan Z (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci 16:6579-6591.
92. Tallaksen-Greene SJ, Albin RL (1994) Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience 61:509-519.
93. Tallaksen-Greene SJ, Albin RL (1996) Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons. Neuroscience 75:1057-1064.
94. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL (1995) Cellular localization of the Huntington s disease protein and discrimination of the normal and mutated form. Nat Genet 10:104-110.
95. Uemura Y, Kowall NW, Beal MF (1990) Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol 27:620-625.
96. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
97. Wanker EE, Rivira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrbach H (1997) HIP-I: a huntingtin-interacting protein isolated by the yeast two-hybrid system. Hum Mol Genet 6:487-495.
98. Wilson CJ (1987) Morphology and synaptic connections of crossed corticostriatal neurons in the rat. J Comp Neurol 263:567-580.
99. Wilson RS, Como PG, Garron DC, Klawans HL, Barr A, Klawans D (1987) Memory failure in Huntington's disease. J Clin Exp Neuropsychol 9a: 147-154.
100. Wood JD, McLaughlin JC, Harper PS, Lowenstein PR, Jones AL (1996) Partial characterization of murine huntingtin and apparent variations in the subcellular localization of huntingtin in human, mouse and rat brain. Hum Mol Genet 5:481-487.
101. Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I, Penney JB (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241:981-983.